The effects of Nobiletin, Hesperetin, and Letrozole in a combination on the activity and expression of aromatase in breast cancer cells

S. T. Rahideh; M. Keramatipour; M. Nourbakhsh; F. Koohdani; M. Hoseini; F. Shidfar

doi:10.14715/cmb/2017.63.2.2

Issue

Vol. 63 No. 2: Issue 2

Issue Published : March 23, 2017

The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.

The effects of Nobiletin, Hesperetin, and Letrozole in a combination on the activity and expression of aromatase in breast cancer cells

https://doi.org/10.14715/cmb/2017.63.2.2

S. T. Rahideh

Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran

M. Keramatipour

Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

M. Nourbakhsh

Department of Biochemistry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

F. Koohdani

Department of Molecular and Cellular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran

M. Hoseini

Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

F. Shidfar

Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran

Corresponding Author(s) : F. Shidfar

shidfar.f@iums.ac.ir

Cellular and Molecular Biology, Vol. 63 No. 2: Issue 2
Article Published : February 28, 2017

Abstract

Nobiletin (NOB) and hesperetin (HES) are the citrus polymethoxyflavone and flavonone. Aromatase or cytochrome P450 (CYP19) enzyme is a key enzyme in estrogen biosynthesis. The objective of this study was to investigate the combinational effects of HES, NOB and letrozole (LET) as aromatase inhibitors on the activity and expression of aromatase in MCF-7 cells. In this study, aromatase enzyme activity based on the conversion of androgen substrate testosterone to 17Î²-Estradiol was determined. Estradiol concentrations were measured using an electrochemiluminescence immunoassay. CYP19 gene expression was determined by quantitative real-time PCR. Our findings demonstrated that none of combinations including LET+NOB, LET+HES, LET+NOB+HES, and NOB+HES had no significant effects on aromatase activity and expression. The present study showed for the first time that the combination of HES, NOB, and LET had no effects on activity and expression of aromatase in MCF-7 breast cancer cells.

Keywords

Nobiletin Hesperetin Letrozole Aromatase Breast cancer MCF-7 cells.

Rahideh, S. T., Keramatipour, M., Nourbakhsh, M., Koohdani, F., Hoseini, M., & Shidfar, F. (2017). The effects of Nobiletin, Hesperetin, and Letrozole in a combination on the activity and expression of aromatase in breast cancer cells. Cellular and Molecular Biology, 63(2), 9–13. https://doi.org/10.14715/cmb/2017.63.2.2